Skip to main content
Clinical Trials/NCT02569580
NCT02569580
Unknown
Not Applicable

Clinical Trial of Anti-Lice Treatment Using the Medical Device "No More" Which is Designed to Kill Lice and Lice Eggs on the Head.

Pharmayeda1 site in 1 country50 target enrollmentStarted: October 2015Last updated:
ConditionsLice

Overview

Phase
Not Applicable
Sponsor
Pharmayeda
Enrollment
50
Locations
1
Primary Endpoint
No live lice eggs and/or live lice

Overview

Brief Summary

The purpose of this study is to determine effectiveness of an Anti-lice treatment using the medical device "No More" which is designed to kill lice and lice eggs on the head.

Detailed Description

The Clinical Trial Protocol include 2 visits

First Visit: Explanation and signing of consent forms. Diagnosis: Prof. Shemer will check if the patients have sufficient living lice or lice eggs and if so they will be scheduled to receive treatment.

Second Visit: -Spread the "No More" on the head of the boy or girl on dry hair.

  • After five minutes comb with an adequately thick comb and the eggs will fall out easily with the pulling of the comb.
  • Wash the hair.
  • Combing the hair again with a thick comb for five minutes and/or 20 combings; Checking if the head is free of eggs and lice via a visual inspection by the head researcher.

Outcome

  1. If there are no live eggs and/or lice then the patient has completed treatment - and the research. (This outcome is defined as successful treatment.)
  2. If there are eggs only then the patient is scheduled for a third visit after seven days (+/- one day).
  3. If live lice are found this outcome is defined as failure and the patient will not be scheduled for an additional visit

Third Visit:

After seven days (+/- one day) Professor Shemer will conduct a visual inspection for lice and lice eggs. Combing with a thick comb for five minutes and/or 20 combings and if there are live lice or lice eggs

Treatment Success:

No eggs and no lice immediately with the end of the treatment (second visit). No lice or live lice eggs after seven days (+/- one day).

Number of Participants: Up to 80 participants when at least 50 participants complete the treatment.

Age Range: 3-18 years

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
3 Years to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients that are suffering from lice and lice eggs that agree to refrain from any other treatment or salve designed for the treatment of lice and/or lice eggs throughout the course of the research study.
  • Patients that orally and in writing express their agreement to participate in the study - Consent in writing will be provided by two parents; Oral consent will be provided by the participants themselves.

Exclusion Criteria

  • Pregnant or nursing women.
  • Patients lacking the faculties for proper judgment.

Outcomes

Primary Outcomes

No live lice eggs and/or live lice

Time Frame: 1 day from second visit

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Pharmayeda
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials